| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteomics | 26 | 2021 | 3447 | 1.300 |
Why?
|
| Tandem Mass Spectrometry | 9 | 2016 | 1144 | 1.200 |
Why?
|
| Protein Kinase Inhibitors | 22 | 2021 | 5457 | 1.180 |
Why?
|
| Cyclin-Dependent Kinases | 10 | 2021 | 668 | 0.940 |
Why?
|
| Phosphopeptides | 9 | 2012 | 244 | 0.870 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 6 | 2011 | 274 | 0.800 |
Why?
|
| Pyrimidines | 10 | 2021 | 2893 | 0.770 |
Why?
|
| Phosphoproteins | 7 | 2016 | 2477 | 0.750 |
Why?
|
| Proteome | 16 | 2022 | 1767 | 0.740 |
Why?
|
| Mass Spectrometry | 18 | 2021 | 2222 | 0.670 |
Why?
|
| Tyrosine | 6 | 2009 | 1471 | 0.550 |
Why?
|
| Saccharomyces cerevisiae Proteins | 10 | 2021 | 1949 | 0.540 |
Why?
|
| Saccharomyces cerevisiae | 10 | 2021 | 2850 | 0.540 |
Why?
|
| Peptides | 7 | 2021 | 4390 | 0.530 |
Why?
|
| Pyrazoles | 4 | 2019 | 1926 | 0.520 |
Why?
|
| Drug Discovery | 8 | 2021 | 1028 | 0.500 |
Why?
|
| CDC2 Protein Kinase | 3 | 2021 | 220 | 0.500 |
Why?
|
| Phosphorylation | 29 | 2023 | 8487 | 0.480 |
Why?
|
| Chromatography, Liquid | 9 | 2021 | 975 | 0.470 |
Why?
|
| Cysteine | 7 | 2020 | 863 | 0.460 |
Why?
|
| RNA Polymerase II | 4 | 2019 | 544 | 0.440 |
Why?
|
| Amines | 1 | 2014 | 282 | 0.430 |
Why?
|
| Cell Fractionation | 3 | 2011 | 280 | 0.430 |
Why?
|
| Anilides | 3 | 2021 | 412 | 0.420 |
Why?
|
| Quinolines | 1 | 2016 | 725 | 0.410 |
Why?
|
| Chromatography, High Pressure Liquid | 7 | 2012 | 1589 | 0.410 |
Why?
|
| Amino Acid Sequence | 26 | 2020 | 13932 | 0.400 |
Why?
|
| Embryonic Stem Cells | 4 | 2013 | 1328 | 0.380 |
Why?
|
| Polyubiquitin | 2 | 2021 | 67 | 0.380 |
Why?
|
| Protein Kinases | 5 | 2019 | 1635 | 0.370 |
Why?
|
| Acrylamides | 3 | 2017 | 233 | 0.370 |
Why?
|
| Cell Line, Tumor | 24 | 2021 | 16630 | 0.360 |
Why?
|
| Protein Processing, Post-Translational | 8 | 2018 | 2007 | 0.360 |
Why?
|
| Crystallography, X-Ray | 15 | 2020 | 1980 | 0.360 |
Why?
|
| Chemical Fractionation | 1 | 2009 | 65 | 0.360 |
Why?
|
| Protein Binding | 21 | 2021 | 9469 | 0.350 |
Why?
|
| Niobium | 1 | 2008 | 2 | 0.340 |
Why?
|
| Ubiquitin | 3 | 2023 | 851 | 0.320 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 2 | 2020 | 437 | 0.310 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 2 | 2023 | 33 | 0.310 |
Why?
|
| Structure-Activity Relationship | 10 | 2023 | 3137 | 0.290 |
Why?
|
| DNA-Binding Proteins | 10 | 2023 | 9716 | 0.290 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2023 | 461 | 0.290 |
Why?
|
| Oxides | 1 | 2008 | 413 | 0.290 |
Why?
|
| Adenine | 3 | 2016 | 909 | 0.280 |
Why?
|
| Catalytic Domain | 7 | 2020 | 696 | 0.280 |
Why?
|
| Phenylenediamines | 2 | 2017 | 90 | 0.270 |
Why?
|
| ras Proteins | 3 | 2017 | 1075 | 0.270 |
Why?
|
| Models, Molecular | 16 | 2020 | 5460 | 0.260 |
Why?
|
| Molecular Structure | 8 | 2021 | 1899 | 0.250 |
Why?
|
| Serum Albumin, Bovine | 1 | 2005 | 332 | 0.240 |
Why?
|
| Signal Transduction | 20 | 2023 | 23448 | 0.240 |
Why?
|
| Drug Design | 5 | 2020 | 1086 | 0.240 |
Why?
|
| Receptor, erbB-3 | 2 | 2015 | 142 | 0.240 |
Why?
|
| Enzyme Inhibitors | 4 | 2021 | 3822 | 0.240 |
Why?
|
| Burkholderia mallei | 1 | 2023 | 3 | 0.240 |
Why?
|
| Acyl Carrier Protein | 1 | 2023 | 23 | 0.240 |
Why?
|
| Small Molecule Libraries | 6 | 2020 | 717 | 0.240 |
Why?
|
| Sperm Capacitation | 1 | 2002 | 26 | 0.230 |
Why?
|
| Protein Unfolding | 2 | 2021 | 59 | 0.230 |
Why?
|
| Nucleocytoplasmic Transport Proteins | 2 | 2021 | 77 | 0.230 |
Why?
|
| Serine | 4 | 2018 | 822 | 0.220 |
Why?
|
| Ubiquitination | 5 | 2023 | 998 | 0.220 |
Why?
|
| Cell Proliferation | 12 | 2021 | 10477 | 0.220 |
Why?
|
| Electrophoresis, Microchip | 1 | 2022 | 14 | 0.220 |
Why?
|
| Molecular Sequence Data | 17 | 2016 | 18301 | 0.220 |
Why?
|
| Ubiquitinated Proteins | 1 | 2021 | 34 | 0.210 |
Why?
|
| Protein Conformation | 11 | 2020 | 4033 | 0.210 |
Why?
|
| BRCA1 Protein | 2 | 2021 | 1114 | 0.200 |
Why?
|
| Chromatography, Ion Exchange | 2 | 2011 | 310 | 0.200 |
Why?
|
| Epitopes | 2 | 2023 | 2560 | 0.200 |
Why?
|
| MAP Kinase Kinase 7 | 1 | 2020 | 14 | 0.200 |
Why?
|
| MAP Kinase Kinase 1 | 2 | 2020 | 346 | 0.200 |
Why?
|
| Gene Expression Regulation, Neoplastic | 8 | 2020 | 8452 | 0.200 |
Why?
|
| Receptors, Androgen | 3 | 2017 | 1035 | 0.200 |
Why?
|
| Transcription, Genetic | 6 | 2020 | 7814 | 0.190 |
Why?
|
| Binding Sites | 10 | 2019 | 6133 | 0.190 |
Why?
|
| Thiazolidines | 1 | 2020 | 77 | 0.190 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2020 | 150 | 0.190 |
Why?
|
| Vesicular Transport Proteins | 2 | 2021 | 376 | 0.190 |
Why?
|
| Urea Cycle Disorders, Inborn | 1 | 2020 | 31 | 0.190 |
Why?
|
| Leukemia, Myeloid, Acute | 4 | 2023 | 3400 | 0.180 |
Why?
|
| Cell Survival | 10 | 2021 | 5914 | 0.180 |
Why?
|
| Chromatography, Affinity | 6 | 2009 | 555 | 0.180 |
Why?
|
| Acetylglucosamine | 3 | 2007 | 195 | 0.180 |
Why?
|
| DNA Damage | 4 | 2021 | 2466 | 0.180 |
Why?
|
| src-Family Kinases | 2 | 2020 | 550 | 0.180 |
Why?
|
| Cryoelectron Microscopy | 2 | 2019 | 557 | 0.180 |
Why?
|
| Antineoplastic Agents | 7 | 2021 | 13576 | 0.180 |
Why?
|
| Threonine | 2 | 2018 | 273 | 0.180 |
Why?
|
| Endopeptidases | 1 | 2023 | 773 | 0.170 |
Why?
|
| Oligopeptides | 1 | 2005 | 1204 | 0.170 |
Why?
|
| Acrylamide | 1 | 2019 | 60 | 0.170 |
Why?
|
| Amides | 2 | 2019 | 450 | 0.170 |
Why?
|
| Amidohydrolases | 1 | 2020 | 172 | 0.170 |
Why?
|
| Androgen Receptor Antagonists | 2 | 2017 | 111 | 0.170 |
Why?
|
| Flavivirus Infections | 1 | 2018 | 15 | 0.170 |
Why?
|
| Flavivirus | 1 | 2018 | 19 | 0.170 |
Why?
|
| Spermatozoa | 1 | 2002 | 621 | 0.170 |
Why?
|
| Caseins | 2 | 2009 | 102 | 0.170 |
Why?
|
| 14-3-3 Proteins | 1 | 2019 | 222 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2018 | 2513 | 0.170 |
Why?
|
| Transcription Factors | 8 | 2023 | 12080 | 0.160 |
Why?
|
| Pluripotent Stem Cells | 2 | 2016 | 795 | 0.160 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2020 | 2947 | 0.160 |
Why?
|
| Promoter Regions, Genetic | 5 | 2021 | 5934 | 0.160 |
Why?
|
| Urea | 1 | 2020 | 440 | 0.160 |
Why?
|
| MAP Kinase Kinase Kinases | 2 | 2016 | 263 | 0.160 |
Why?
|
| Humans | 83 | 2023 | 725187 | 0.150 |
Why?
|
| Ribonucleoproteins | 2 | 2014 | 384 | 0.150 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 4 | 2008 | 500 | 0.150 |
Why?
|
| Cell Cycle Proteins | 3 | 2020 | 3467 | 0.150 |
Why?
|
| Dioxolanes | 1 | 2016 | 23 | 0.150 |
Why?
|
| Viral Proteins | 2 | 2016 | 1952 | 0.150 |
Why?
|
| TATA-Binding Protein Associated Factors | 1 | 2017 | 106 | 0.150 |
Why?
|
| HeLa Cells | 8 | 2018 | 3165 | 0.150 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2016 | 96 | 0.150 |
Why?
|
| Jurkat Cells | 6 | 2020 | 749 | 0.150 |
Why?
|
| Animals | 37 | 2023 | 168714 | 0.140 |
Why?
|
| Arginine | 1 | 2020 | 949 | 0.140 |
Why?
|
| Mice | 24 | 2021 | 80300 | 0.140 |
Why?
|
| Protease Inhibitors | 1 | 2020 | 799 | 0.140 |
Why?
|
| Multienzyme Complexes | 1 | 2019 | 695 | 0.140 |
Why?
|
| Janus Kinase 3 | 1 | 2015 | 80 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2021 | 1002 | 0.130 |
Why?
|
| Cyclophilin A | 1 | 2015 | 58 | 0.130 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2016 | 222 | 0.130 |
Why?
|
| Software | 3 | 2017 | 4406 | 0.130 |
Why?
|
| Antiviral Agents | 2 | 2018 | 2895 | 0.130 |
Why?
|
| Telomere | 1 | 2021 | 916 | 0.130 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2017 | 388 | 0.130 |
Why?
|
| Guanosine Diphosphate | 1 | 2014 | 86 | 0.130 |
Why?
|
| Receptors, Calcitriol | 1 | 2017 | 348 | 0.130 |
Why?
|
| Viral Envelope Proteins | 1 | 2018 | 643 | 0.120 |
Why?
|
| Virus Internalization | 1 | 2018 | 492 | 0.120 |
Why?
|
| Protein Biosynthesis | 3 | 2018 | 2139 | 0.120 |
Why?
|
| Cell Cycle | 2 | 2021 | 2980 | 0.120 |
Why?
|
| Elafin | 1 | 2014 | 31 | 0.120 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2018 | 648 | 0.120 |
Why?
|
| Glutathione | 1 | 2016 | 596 | 0.120 |
Why?
|
| Chemokine CXCL12 | 1 | 2016 | 465 | 0.120 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2013 | 1712 | 0.120 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2020 | 5171 | 0.120 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2016 | 483 | 0.120 |
Why?
|
| Apoptosis | 6 | 2021 | 9756 | 0.120 |
Why?
|
| Cell Extracts | 2 | 2011 | 144 | 0.110 |
Why?
|
| Indicators and Reagents | 1 | 2014 | 465 | 0.110 |
Why?
|
| HCT116 Cells | 3 | 2019 | 411 | 0.110 |
Why?
|
| Adenosine Triphosphate | 2 | 2017 | 2036 | 0.110 |
Why?
|
| Enzyme Activation | 6 | 2019 | 3739 | 0.110 |
Why?
|
| Molecular Targeted Therapy | 4 | 2020 | 2760 | 0.110 |
Why?
|
| GTPase-Activating Proteins | 1 | 2016 | 487 | 0.110 |
Why?
|
| Fourier Analysis | 1 | 2014 | 449 | 0.110 |
Why?
|
| Oncogenic Viruses | 1 | 2012 | 43 | 0.110 |
Why?
|
| Insulin-Secreting Cells | 1 | 2020 | 875 | 0.110 |
Why?
|
| Alternative Splicing | 2 | 2018 | 1121 | 0.110 |
Why?
|
| Germ Layers | 1 | 2013 | 76 | 0.110 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2014 | 431 | 0.110 |
Why?
|
| Proteins | 7 | 2021 | 6088 | 0.110 |
Why?
|
| Janus Kinases | 1 | 2013 | 228 | 0.110 |
Why?
|
| Metals | 2 | 2009 | 690 | 0.110 |
Why?
|
| Acetamides | 1 | 2014 | 251 | 0.110 |
Why?
|
| Pyrroles | 1 | 2019 | 1142 | 0.110 |
Why?
|
| Cytomegalovirus | 1 | 2016 | 718 | 0.110 |
Why?
|
| Peptide Fragments | 4 | 2014 | 5037 | 0.110 |
Why?
|
| Isotope Labeling | 1 | 2014 | 412 | 0.110 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2020 | 2937 | 0.110 |
Why?
|
| Drug Screening Assays, Antitumor | 3 | 2021 | 740 | 0.110 |
Why?
|
| Protein Structure, Tertiary | 6 | 2017 | 3902 | 0.110 |
Why?
|
| Chromatography, Reverse-Phase | 1 | 2011 | 22 | 0.110 |
Why?
|
| Peptide Library | 1 | 2013 | 342 | 0.100 |
Why?
|
| Replication Protein A | 1 | 2011 | 71 | 0.100 |
Why?
|
| Sequence Analysis, Protein | 1 | 2013 | 257 | 0.100 |
Why?
|
| Computational Biology | 2 | 2017 | 3526 | 0.100 |
Why?
|
| Cell Line | 7 | 2019 | 16263 | 0.100 |
Why?
|
| Amino Acid Motifs | 3 | 2020 | 951 | 0.100 |
Why?
|
| Receptor, erbB-2 | 2 | 2014 | 2335 | 0.100 |
Why?
|
| Genes, ras | 1 | 2014 | 708 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 8 | 2021 | 22134 | 0.100 |
Why?
|
| Metabolome | 1 | 2017 | 855 | 0.100 |
Why?
|
| Ribosomal Proteins | 2 | 2016 | 364 | 0.100 |
Why?
|
| Automation, Laboratory | 1 | 2011 | 99 | 0.100 |
Why?
|
| DNA, Fungal | 1 | 2012 | 293 | 0.100 |
Why?
|
| Carrier Proteins | 2 | 2014 | 5041 | 0.100 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2012 | 289 | 0.100 |
Why?
|
| Hepatocytes | 1 | 2017 | 1196 | 0.100 |
Why?
|
| Sulfonamides | 1 | 2020 | 1882 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase 9 | 1 | 2010 | 64 | 0.100 |
Why?
|
| Piperidines | 2 | 2016 | 1565 | 0.100 |
Why?
|
| Quinazolines | 1 | 2017 | 1365 | 0.100 |
Why?
|
| HEK293 Cells | 5 | 2020 | 4225 | 0.100 |
Why?
|
| Listeriosis | 1 | 2011 | 149 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2014 | 588 | 0.090 |
Why?
|
| Genes, Neoplasm | 1 | 2012 | 383 | 0.090 |
Why?
|
| MAP Kinase Signaling System | 4 | 2017 | 1534 | 0.090 |
Why?
|
| Nuclear Proteins | 5 | 2014 | 5913 | 0.090 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2014 | 399 | 0.090 |
Why?
|
| Receptor, Notch1 | 1 | 2013 | 513 | 0.090 |
Why?
|
| Substrate Specificity | 3 | 2019 | 1803 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2021 | 10971 | 0.090 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2014 | 454 | 0.090 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2012 | 719 | 0.090 |
Why?
|
| DNA, Single-Stranded | 1 | 2011 | 387 | 0.090 |
Why?
|
| rho-Associated Kinases | 1 | 2011 | 281 | 0.090 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2023 | 3574 | 0.090 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2019 | 2004 | 0.090 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2010 | 188 | 0.090 |
Why?
|
| Microsomes, Liver | 2 | 2021 | 181 | 0.090 |
Why?
|
| Miniaturization | 1 | 2009 | 155 | 0.090 |
Why?
|
| Oxidative Phosphorylation | 3 | 2016 | 482 | 0.090 |
Why?
|
| Disaccharides | 1 | 2009 | 173 | 0.090 |
Why?
|
| Autophagy | 1 | 2017 | 1306 | 0.080 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2011 | 516 | 0.080 |
Why?
|
| Thermotoga maritima | 1 | 2008 | 12 | 0.080 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2023 | 3353 | 0.080 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2008 | 100 | 0.080 |
Why?
|
| Olfactory Bulb | 1 | 2009 | 200 | 0.080 |
Why?
|
| Pyridines | 1 | 2020 | 2807 | 0.080 |
Why?
|
| Trypsin | 4 | 2013 | 518 | 0.080 |
Why?
|
| Glucose | 1 | 2020 | 4315 | 0.080 |
Why?
|
| Immunotherapy | 1 | 2023 | 4257 | 0.080 |
Why?
|
| Breast | 1 | 2017 | 1916 | 0.080 |
Why?
|
| Neoplasm Proteins | 2 | 2017 | 3711 | 0.080 |
Why?
|
| Chelating Agents | 1 | 2009 | 382 | 0.080 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2008 | 135 | 0.080 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2018 | 2031 | 0.080 |
Why?
|
| Oncogene Proteins | 1 | 2012 | 756 | 0.080 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2011 | 498 | 0.080 |
Why?
|
| DNA Repair | 2 | 2014 | 2047 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 4 | 2021 | 6371 | 0.080 |
Why?
|
| Pol1 Transcription Initiation Complex Proteins | 1 | 2006 | 10 | 0.080 |
Why?
|
| Oncogenes | 1 | 2013 | 1269 | 0.080 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2017 | 1846 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 2 | 2023 | 76 | 0.080 |
Why?
|
| Myeloid Cells | 1 | 2012 | 795 | 0.080 |
Why?
|
| Fibroblasts | 2 | 2016 | 4198 | 0.080 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 2 | 2016 | 1319 | 0.080 |
Why?
|
| RNA-Binding Proteins | 1 | 2016 | 1907 | 0.070 |
Why?
|
| Bone Marrow | 2 | 2015 | 2908 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2018 | 3479 | 0.070 |
Why?
|
| Protein Multimerization | 3 | 2019 | 972 | 0.070 |
Why?
|
| High-Throughput Screening Assays | 3 | 2020 | 934 | 0.070 |
Why?
|
| Peptide Mapping | 1 | 2006 | 267 | 0.070 |
Why?
|
| Protein Phosphatase 2 | 1 | 2008 | 229 | 0.070 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2014 | 2431 | 0.070 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2009 | 1850 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2017 | 2943 | 0.070 |
Why?
|
| Adaptive Immunity | 1 | 2011 | 703 | 0.070 |
Why?
|
| Gene Expression Profiling | 6 | 2017 | 9379 | 0.070 |
Why?
|
| Magnetics | 1 | 2009 | 615 | 0.070 |
Why?
|
| Cytidine Deaminase | 1 | 2008 | 250 | 0.070 |
Why?
|
| Isoenzymes | 2 | 2009 | 1748 | 0.070 |
Why?
|
| Citric Acid Cycle | 2 | 2020 | 231 | 0.070 |
Why?
|
| Mitochondria | 2 | 2016 | 3586 | 0.070 |
Why?
|
| RNA, Ribosomal | 1 | 2006 | 249 | 0.070 |
Why?
|
| Multiprotein Complexes | 3 | 2019 | 1145 | 0.070 |
Why?
|
| Affinity Labels | 1 | 2005 | 111 | 0.070 |
Why?
|
| Reproducibility of Results | 4 | 2012 | 19624 | 0.070 |
Why?
|
| Fluorine | 1 | 2005 | 83 | 0.070 |
Why?
|
| Glioma | 2 | 2017 | 3318 | 0.070 |
Why?
|
| Automation | 2 | 2005 | 586 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2015 | 2877 | 0.060 |
Why?
|
| Protein Folding | 1 | 2008 | 845 | 0.060 |
Why?
|
| Electron Transport Complex IV | 1 | 2004 | 194 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2009 | 2574 | 0.060 |
Why?
|
| Phosphotyrosine | 1 | 2004 | 459 | 0.060 |
Why?
|
| Protein Transport | 2 | 2021 | 2015 | 0.060 |
Why?
|
| Drug Delivery Systems | 1 | 2015 | 2230 | 0.060 |
Why?
|
| Methylation | 3 | 2016 | 1112 | 0.060 |
Why?
|
| Liver | 2 | 2017 | 7494 | 0.060 |
Why?
|
| Host-Pathogen Interactions | 1 | 2012 | 1469 | 0.060 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2017 | 483 | 0.060 |
Why?
|
| Pancreatic Neoplasms | 2 | 2020 | 5094 | 0.060 |
Why?
|
| RNA, Small Interfering | 3 | 2021 | 3529 | 0.060 |
Why?
|
| Chromatin | 2 | 2012 | 2849 | 0.060 |
Why?
|
| Lung Neoplasms | 2 | 2020 | 12870 | 0.060 |
Why?
|
| Protein Array Analysis | 1 | 2005 | 412 | 0.060 |
Why?
|
| Conserved Sequence | 2 | 2018 | 1202 | 0.060 |
Why?
|
| Database Management Systems | 2 | 2017 | 272 | 0.050 |
Why?
|
| Epitope Mapping | 1 | 2023 | 312 | 0.050 |
Why?
|
| Antigen-Antibody Reactions | 1 | 2002 | 370 | 0.050 |
Why?
|
| Adenosine Triphosphatases | 2 | 2006 | 843 | 0.050 |
Why?
|
| Electrophoresis, Capillary | 1 | 2022 | 68 | 0.050 |
Why?
|
| Chromatography | 1 | 2002 | 210 | 0.050 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2004 | 495 | 0.050 |
Why?
|
| Cells, Cultured | 6 | 2021 | 19485 | 0.050 |
Why?
|
| Bacterial Proteins | 2 | 2023 | 3865 | 0.050 |
Why?
|
| Bone Marrow Transplantation | 2 | 2023 | 2768 | 0.050 |
Why?
|
| Ligands | 3 | 2019 | 3282 | 0.050 |
Why?
|
| Mammals | 2 | 2023 | 1079 | 0.050 |
Why?
|
| Receptors, Antigen, B-Cell | 2 | 2016 | 557 | 0.050 |
Why?
|
| Antigens, CD34 | 1 | 2023 | 653 | 0.050 |
Why?
|
| Protein Isoforms | 2 | 2018 | 1717 | 0.050 |
Why?
|
| Mutation | 8 | 2021 | 29672 | 0.050 |
Why?
|
| Exoribonucleases | 1 | 2021 | 89 | 0.050 |
Why?
|
| Cell Differentiation | 3 | 2014 | 11507 | 0.050 |
Why?
|
| Neuronal Plasticity | 1 | 2009 | 1402 | 0.050 |
Why?
|
| Pyruvate Carboxylase | 1 | 2020 | 17 | 0.050 |
Why?
|
| Tumor Escape | 1 | 2023 | 346 | 0.050 |
Why?
|
| Brain Chemistry | 1 | 2004 | 1002 | 0.050 |
Why?
|
| Cyclic AMP | 1 | 2004 | 1476 | 0.050 |
Why?
|
| Allosteric Regulation | 2 | 2016 | 410 | 0.050 |
Why?
|
| RNA Helicases | 1 | 2021 | 149 | 0.050 |
Why?
|
| Inflammation | 1 | 2020 | 10335 | 0.050 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2023 | 503 | 0.050 |
Why?
|
| Sensitivity and Specificity | 4 | 2009 | 14721 | 0.050 |
Why?
|
| Biotechnology | 1 | 2002 | 267 | 0.050 |
Why?
|
| Nanotechnology | 3 | 2011 | 694 | 0.050 |
Why?
|
| Neoplasms | 2 | 2023 | 20941 | 0.050 |
Why?
|
| Databases as Topic | 1 | 2002 | 476 | 0.050 |
Why?
|
| Peptide Hydrolases | 1 | 2023 | 626 | 0.050 |
Why?
|
| Breast Neoplasms | 3 | 2017 | 20448 | 0.040 |
Why?
|
| Gene Deletion | 2 | 2020 | 2798 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2017 | 2863 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2020 | 2974 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2011 | 4308 | 0.040 |
Why?
|
| Hematopoiesis | 2 | 2023 | 2056 | 0.040 |
Why?
|
| Peptide Elongation Factors | 1 | 2019 | 62 | 0.040 |
Why?
|
| DNA Replication | 1 | 2006 | 1443 | 0.040 |
Why?
|
| Genome, Human | 1 | 2012 | 4430 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2007 | 2297 | 0.040 |
Why?
|
| Prostatic Neoplasms | 2 | 2017 | 10884 | 0.040 |
Why?
|
| Oxidation-Reduction | 2 | 2016 | 2197 | 0.040 |
Why?
|
| Gene Regulatory Networks | 2 | 2017 | 1719 | 0.040 |
Why?
|
| NIH 3T3 Cells | 1 | 2020 | 681 | 0.040 |
Why?
|
| Kinetics | 4 | 2010 | 6554 | 0.040 |
Why?
|
| Transfection | 4 | 2010 | 5965 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2021 | 900 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2017 | 1739 | 0.040 |
Why?
|
| Glycosylation | 3 | 2007 | 1109 | 0.040 |
Why?
|
| Bile Acids and Salts | 1 | 2020 | 355 | 0.040 |
Why?
|
| Aspartic Acid | 1 | 2020 | 573 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2023 | 1295 | 0.040 |
Why?
|
| Protein Kinase C | 2 | 2018 | 1239 | 0.040 |
Why?
|
| Position-Specific Scoring Matrices | 1 | 2017 | 11 | 0.040 |
Why?
|
| Multiple Myeloma | 1 | 2015 | 5068 | 0.040 |
Why?
|
| Peptide Elongation Factor G | 1 | 2016 | 14 | 0.040 |
Why?
|
| Peptide Elongation Factor Tu | 1 | 2016 | 18 | 0.040 |
Why?
|
| Algorithms | 3 | 2009 | 13765 | 0.040 |
Why?
|
| User-Computer Interface | 2 | 2017 | 1421 | 0.040 |
Why?
|
| Ovarian Neoplasms | 1 | 2014 | 4754 | 0.040 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2016 | 39 | 0.040 |
Why?
|
| Phosphoserine | 1 | 2017 | 210 | 0.040 |
Why?
|
| Allosteric Site | 1 | 2016 | 104 | 0.040 |
Why?
|
| CpG Islands | 1 | 2021 | 1202 | 0.040 |
Why?
|
| Protein Subunits | 2 | 2014 | 978 | 0.040 |
Why?
|
| Casein Kinase II | 1 | 2017 | 126 | 0.040 |
Why?
|
| Histones | 2 | 2017 | 2559 | 0.040 |
Why?
|
| Transplantation Conditioning | 1 | 2023 | 1553 | 0.040 |
Why?
|
| Dengue Virus | 1 | 2018 | 195 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 2 | 2012 | 1666 | 0.040 |
Why?
|
| Mice, Knockout | 3 | 2020 | 14769 | 0.040 |
Why?
|
| RNA Interference | 2 | 2016 | 2956 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2013 | 7921 | 0.040 |
Why?
|
| T-Lymphocytes | 2 | 2023 | 10007 | 0.040 |
Why?
|
| Escherichia coli | 2 | 2023 | 4278 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 2023 | 9245 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2016 | 13044 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2021 | 1298 | 0.030 |
Why?
|
| Male | 12 | 2021 | 347096 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2021 | 1320 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2021 | 895 | 0.030 |
Why?
|
| Obesity | 1 | 2017 | 12419 | 0.030 |
Why?
|
| Acetylcysteine | 1 | 2016 | 272 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2002 | 2785 | 0.030 |
Why?
|
| Escherichia coli Proteins | 2 | 2013 | 1097 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2000 | 1271 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2017 | 432 | 0.030 |
Why?
|
| COS Cells | 2 | 2010 | 1187 | 0.030 |
Why?
|
| Biological Availability | 1 | 2015 | 391 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2021 | 2650 | 0.030 |
Why?
|
| Acetylation | 1 | 2017 | 1112 | 0.030 |
Why?
|
| Histone Chaperones | 1 | 2014 | 77 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2014 | 5236 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2015 | 461 | 0.030 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2000 | 1344 | 0.030 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2014 | 110 | 0.030 |
Why?
|
| Protein Interaction Mapping | 1 | 2017 | 636 | 0.030 |
Why?
|
| Nucleotides | 1 | 2016 | 460 | 0.030 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2016 | 638 | 0.030 |
Why?
|
| Guanosine Triphosphate | 1 | 2014 | 327 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2002 | 3965 | 0.030 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2013 | 96 | 0.030 |
Why?
|
| Adamantane | 1 | 2014 | 174 | 0.030 |
Why?
|
| Biotin | 1 | 2014 | 266 | 0.030 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2014 | 420 | 0.030 |
Why?
|
| Ecosystem | 1 | 2017 | 453 | 0.030 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2014 | 236 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 2017 | 6669 | 0.030 |
Why?
|
| Protein Stability | 1 | 2014 | 559 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2020 | 1667 | 0.030 |
Why?
|
| Carbon | 1 | 2016 | 671 | 0.030 |
Why?
|
| bcl-X Protein | 1 | 2014 | 391 | 0.030 |
Why?
|
| Gene Expression | 2 | 2017 | 7819 | 0.030 |
Why?
|
| Chromosomes, Human | 1 | 2014 | 460 | 0.030 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2013 | 124 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2017 | 2272 | 0.030 |
Why?
|
| Lysine | 1 | 2016 | 1005 | 0.030 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2012 | 153 | 0.030 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2014 | 346 | 0.030 |
Why?
|
| Peptide Chain Elongation, Translational | 1 | 2011 | 35 | 0.030 |
Why?
|
| Lysosomes | 1 | 2017 | 906 | 0.030 |
Why?
|
| I-kappa B Kinase | 1 | 2013 | 256 | 0.030 |
Why?
|
| Metabolomics | 1 | 2020 | 1421 | 0.030 |
Why?
|